Geron CorpNASDAQ:GERN
- LAST PRICE3.7700
- TODAY'S CHANGE (%)0.1100 (3.0055%)
- Bid / Lots3.7600/ 21
- Ask / Lots3.9000/ 13
- Open / Previous Close3.6850 / 3.6600
- Day Range
- 52 Week Range
- Volume11,557,942
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GERN |
|---|---|---|
| 09:32 ET | 64405 | 3.64 |
| 09:33 ET | 15284 | 3.68 |
| 09:35 ET | 3002 | 3.675 |
| 09:37 ET | 11400 | 3.685 |
| 09:39 ET | 24337 | 3.68 |
| 09:42 ET | 3800 | 3.685 |
| 09:44 ET | 9536 | 3.6503 |
| 09:46 ET | 17586 | 3.64 |
| 09:48 ET | 12390 | 3.64 |
| 09:50 ET | 12600 | 3.64 |
| 09:51 ET | 7390 | 3.655 |
| 09:53 ET | 57823 | 3.63 |
| 09:55 ET | 134958 | 3.605 |
| 09:57 ET | 18393 | 3.63 |
| 10:00 ET | 2300 | 3.6257 |
| 10:02 ET | 27921 | 3.61 |
| 10:04 ET | 9384 | 3.63 |
| 10:06 ET | 23943 | 3.63 |
| 10:08 ET | 27343 | 3.63 |
| 10:09 ET | 19567 | 3.63 |
| 10:11 ET | 26626 | 3.645 |
| 10:13 ET | 485 | 3.645 |
| 10:15 ET | 10696 | 3.6399 |
| 10:18 ET | 70999 | 3.655 |
| 10:20 ET | 3105 | 3.653898 |
| 10:22 ET | 73313 | 3.685 |
| 10:24 ET | 25944 | 3.67 |
| 10:26 ET | 13173 | 3.675 |
| 10:27 ET | 48102 | 3.675 |
| 10:29 ET | 50803 | 3.685 |
| 10:31 ET | 13066 | 3.68 |
| 10:33 ET | 68990 | 3.69 |
| 10:36 ET | 109954 | 3.7 |
| 10:38 ET | 75191 | 3.7054 |
| 10:40 ET | 49873 | 3.705 |
| 10:42 ET | 474148 | 3.735 |
| 10:44 ET | 65238 | 3.765 |
| 10:45 ET | 48545 | 3.76 |
| 10:47 ET | 5301 | 3.755 |
| 10:49 ET | 12888 | 3.75 |
| 10:51 ET | 11849 | 3.753896 |
| 10:54 ET | 3348 | 3.755 |
| 10:56 ET | 43872 | 3.74 |
| 10:58 ET | 18727 | 3.74 |
| 11:00 ET | 9848 | 3.725 |
| 11:02 ET | 13639 | 3.715 |
| 11:03 ET | 7004 | 3.72 |
| 11:05 ET | 11120 | 3.71 |
| 11:07 ET | 6150 | 3.71 |
| 11:09 ET | 4609 | 3.7049 |
| 11:12 ET | 13793 | 3.7 |
| 11:14 ET | 20588 | 3.69 |
| 11:16 ET | 21982 | 3.705 |
| 11:18 ET | 12152 | 3.6999 |
| 11:20 ET | 7826 | 3.7 |
| 11:21 ET | 12782 | 3.6889 |
| 11:23 ET | 1262 | 3.69 |
| 11:25 ET | 4700 | 3.68 |
| 11:27 ET | 42655 | 3.69 |
| 11:30 ET | 7650 | 3.69 |
| 11:32 ET | 14783 | 3.685 |
| 11:34 ET | 400 | 3.69 |
| 11:36 ET | 2200 | 3.69 |
| 11:38 ET | 1750 | 3.69 |
| 11:39 ET | 3574 | 3.6889 |
| 11:41 ET | 1600 | 3.685 |
| 11:43 ET | 4100 | 3.6892 |
| 11:45 ET | 3871 | 3.68 |
| 11:48 ET | 16574 | 3.6892 |
| 11:50 ET | 700 | 3.685 |
| 11:52 ET | 6100 | 3.68 |
| 11:54 ET | 1800 | 3.685 |
| 11:56 ET | 111230 | 3.705 |
| 11:57 ET | 44325 | 3.72 |
| 11:59 ET | 13563 | 3.725 |
| 12:01 ET | 463879 | 3.71 |
| 12:03 ET | 50863 | 3.72 |
| 12:08 ET | 700 | 3.7288 |
| 12:10 ET | 750 | 3.73 |
| 12:12 ET | 4000 | 3.73 |
| 12:14 ET | 10228 | 3.705 |
| 12:15 ET | 5938 | 3.7061 |
| 12:17 ET | 4006 | 3.705 |
| 12:19 ET | 11927 | 3.71 |
| 12:21 ET | 185630 | 3.74 |
| 12:24 ET | 11927 | 3.725 |
| 12:26 ET | 200 | 3.73 |
| 12:28 ET | 10872 | 3.735 |
| 12:30 ET | 3700 | 3.735 |
| 12:32 ET | 6845 | 3.735 |
| 12:33 ET | 6676 | 3.735 |
| 12:35 ET | 7264 | 3.735 |
| 12:37 ET | 950 | 3.735 |
| 12:39 ET | 3300 | 3.74 |
| 12:42 ET | 14018 | 3.735 |
| 12:44 ET | 37293 | 3.72 |
| 12:46 ET | 11408 | 3.705 |
| 12:48 ET | 50693 | 3.7 |
| 12:50 ET | 5245 | 3.7 |
| 12:51 ET | 12502 | 3.705 |
| 12:53 ET | 4302 | 3.705 |
| 12:55 ET | 7113 | 3.7 |
| 12:57 ET | 11033 | 3.705 |
| 01:00 ET | 3100 | 3.7 |
| 01:02 ET | 501547 | 3.71 |
| 01:04 ET | 22002 | 3.69 |
| 01:06 ET | 14375 | 3.71 |
| 01:08 ET | 16624 | 3.7093 |
| 01:09 ET | 7600 | 3.7059 |
| 01:11 ET | 2900 | 3.7 |
| 01:13 ET | 3800 | 3.705 |
| 01:15 ET | 12489 | 3.69 |
| 01:18 ET | 30810 | 3.705 |
| 01:20 ET | 1817 | 3.7082 |
| 01:22 ET | 16505 | 3.705 |
| 01:24 ET | 16507 | 3.705 |
| 01:26 ET | 7277 | 3.705 |
| 01:27 ET | 6685 | 3.7 |
| 01:29 ET | 4674 | 3.705 |
| 01:31 ET | 6376 | 3.705 |
| 01:33 ET | 7506 | 3.7 |
| 01:36 ET | 7405 | 3.7 |
| 01:38 ET | 22893 | 3.695 |
| 01:40 ET | 1373 | 3.695 |
| 01:42 ET | 18884 | 3.71 |
| 01:44 ET | 21043 | 3.71 |
| 01:45 ET | 2400 | 3.71 |
| 01:47 ET | 3500 | 3.705 |
| 01:49 ET | 20083 | 3.715 |
| 01:51 ET | 31729 | 3.71 |
| 01:54 ET | 43733 | 3.73 |
| 01:56 ET | 57823 | 3.745 |
| 01:58 ET | 26001 | 3.755 |
| 02:00 ET | 63750 | 3.77 |
| 02:02 ET | 16888 | 3.78 |
| 02:03 ET | 95136 | 3.775 |
| 02:05 ET | 17110 | 3.785 |
| 02:07 ET | 3800 | 3.79 |
| 02:09 ET | 4659 | 3.79 |
| 02:12 ET | 30352 | 3.785 |
| 02:14 ET | 72016 | 3.765 |
| 02:16 ET | 7750 | 3.77 |
| 02:18 ET | 6000 | 3.765 |
| 02:20 ET | 5642 | 3.765 |
| 02:21 ET | 13257 | 3.7654 |
| 02:23 ET | 24882 | 3.765 |
| 02:25 ET | 3903 | 3.76 |
| 02:27 ET | 5774 | 3.765 |
| 02:30 ET | 2400 | 3.76 |
| 02:32 ET | 5110 | 3.765 |
| 02:34 ET | 3014 | 3.7695 |
| 02:36 ET | 358573 | 3.765 |
| 02:38 ET | 77286 | 3.77 |
| 02:39 ET | 23676 | 3.765 |
| 02:41 ET | 274408 | 3.77 |
| 02:43 ET | 30857 | 3.775 |
| 02:45 ET | 28430 | 3.765 |
| 02:48 ET | 9488 | 3.76 |
| 02:50 ET | 22179 | 3.765 |
| 02:52 ET | 94454 | 3.755 |
| 02:54 ET | 1000 | 3.75 |
| 02:56 ET | 8404 | 3.76 |
| 02:57 ET | 2257 | 3.755 |
| 02:59 ET | 3005 | 3.755 |
| 03:01 ET | 3672 | 3.755 |
| 03:03 ET | 34561 | 3.77 |
| 03:06 ET | 12187 | 3.765 |
| 03:08 ET | 47768 | 3.77 |
| 03:10 ET | 2670 | 3.77 |
| 03:12 ET | 52163 | 3.775 |
| 03:14 ET | 60469 | 3.775 |
| 03:15 ET | 26661 | 3.765 |
| 03:17 ET | 1301 | 3.76 |
| 03:19 ET | 2550 | 3.77 |
| 03:21 ET | 13386 | 3.78 |
| 03:24 ET | 15509 | 3.785 |
| 03:26 ET | 4251 | 3.785 |
| 03:28 ET | 5545 | 3.785 |
| 03:30 ET | 171518 | 3.8 |
| 03:32 ET | 21177 | 3.8 |
| 03:33 ET | 13429 | 3.8 |
| 03:35 ET | 265265 | 3.825 |
| 03:37 ET | 220810 | 3.84 |
| 03:39 ET | 357412 | 3.815 |
| 03:42 ET | 191374 | 3.855 |
| 03:44 ET | 48117 | 3.845 |
| 03:46 ET | 35188 | 3.8498 |
| 03:48 ET | 63176 | 3.83 |
| 03:50 ET | 231808 | 3.845 |
| 03:51 ET | 250556 | 3.845 |
| 03:53 ET | 141861 | 3.85 |
| 03:55 ET | 524021 | 3.825 |
| 03:57 ET | 419406 | 3.8 |
| 04:00 ET | 2440055 | 3.77 |
Nov 11, 2024
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development, from 4:30PM ET on Monday Nov 11, 2024 by Dow Jones
4:30PM ET on Monday Nov 11, 2024 by Dow JonesGeron to Participate in the Stifel 2024 Healthcare Conference, from 9:00AM ET on Monday Nov 11, 2024 by Dow Jones
9:00AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million, from 7:10AM ET on Thursday Nov 07, 2024 by Dow Jones
7:10AM ET on Thursday Nov 07, 2024 by Dow JonesGeron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors, from 7:01AM ET on Thursday Nov 07, 2024 by Dow Jones
7:01AM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Geron 3Q Loss/Shr 4c >GERN, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Geron Corp | 2.2B | -11.7x | --- |
CG Oncology Inc | 2.2B | -27.9x | --- |
Soleno Therapeutics Inc | 2.2B | -15.6x | --- |
Keros Therapeutics Inc | 2.3B | -10.4x | --- |
Longboard Pharmaceuticals Inc | 2.3B | -26.7x | --- |
NewAmsterdam Pharma Company NV | 2.3B | -11.0x | --- |
Company Information
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Contact Information
- Headquarters
- 919 East Hillsdale Boulevard, Suite 250FOSTER CITY, CA, United States 94404
- Phone
- 650-473-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board, President, Chief Executive Officer
- John Scarlett
- Chief Financial Officer, Executive Vice President - Finance, Treasurer
- Michelle Robertson
- Executive Vice President, Chief Operating Officer
- Andrew Grethlein
- Chief People Officer, Senior Vice President
- Shannon Odam
- Executive Vice President, Chief Legal Officer, Secretary
- Scott Samuels
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.2B |
|---|---|
Revenue (TTM) | $29.5M |
Shares Outstanding | 602.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $-0.32 |
Book Value | $0.46 |
P/E Ratio | -11.7x |
Price/Sales (TTM) | 74.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -705.46% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
